<DOC>
	<DOCNO>NCT00006027</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor tissue . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . It yet know radiation therapy effective without combination chemotherapy endometrial cancer . PURPOSE : Randomized phase III trial compare effectiveness radiation therapy without combination chemotherapy follow surgery treat patient stage I stage II endometrial cancer .</brief_summary>
	<brief_title>Comparison Radiation Therapy With Without Combination Chemotherapy Following Surgery Treating Patients With Stage I Stage II Endometrial Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare relapse-free survival patient stage I II endometrial cancer treat adjuvant radiotherapy without cisplatin paclitaxel total abdominal hysterectomy bilateral salpingo-oophorectomy . - Compare pattern recurrence acute late toxicity profile associate treatment regimens patient population . OUTLINE : This randomize , multicenter study . Patients stratify accord disease stage ( IC-IIA v IIB ) . Patients randomize one two treatment arm . - Arm I : Within 8 week surgery , patient receive radiotherapy daily 5 day week 5.5 week . - Arm II : Within 8 week surgery , patient receive radiotherapy arm I concurrently cisplatin IV 2-4 hour day 1 28 . After completion radiotherapy , patient receive paclitaxel IV 3 hour follow cisplatin IV 2-4 hour day 56 , 84 , 112 , 140 . Patients follow every 3 month 1 year , every 6 month 3 year , annually thereafter . PROJECTED ACCRUAL : A total 436 patient ( 218 per treatment arm ) accrue study .</detailed_description>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm uterine confine endometrioid endometrial adenocarcinoma one following : Grade 2 3 carcinoma 50 % myometrial invasion ( stage IC IIA ) Grade 2 3 carcinoma stromal invasion cervix ( stage IIB ) No grade I adenocarcinoma Less 50 % papillary serous clear cell histology pathologic specimen Prior hysterectomy ( total abdominal , vaginal hysterectomy , laparoscopicassisted vaginal hysterectomy ) bilateral salpingooophorectomy without additional surgical stag endometrial cancer 8 week prior study No know metastatic extrauterine metastasis , know gross residual disease , positive peritoneal cytology , distant metastasis PATIENT CHARACTERISTICS : Age : 18 Performance status : Zubrod 01 Life expectancy : Not specify Hematopoietic : Absolute neutrophil count least 1,800/mm^3 Platelet count least 100,000/mm^3 Hemoglobin least 10 g/dL Hepatic : Bilirubin great 1.5 time normal SGOT great 3 time normal Renal : Creatinine great 1.5 mg/dL Cardiovascular : No cardiac dysrhythmias Other : No malignancy within past 5 year except nonmelanomatous skin cancer No medical contraindication study therapy PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy Surgery : See Disease Characteristics</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>stage I endometrial carcinoma</keyword>
	<keyword>stage II endometrial carcinoma</keyword>
	<keyword>endometrial adenocarcinoma</keyword>
	<keyword>endometrial adenosquamous cell carcinoma</keyword>
	<keyword>endometrial adenoacanthoma</keyword>
	<keyword>endometrial clear cell carcinoma</keyword>
	<keyword>endometrial papillary serous carcinoma</keyword>
</DOC>